Biomarker-guided classification scheme of neurodegenerative diseases

被引：18

作者：

Baldacci, Filippo ^{[1
,2
,3
]}

Lista, Simone ^{[4
,5
,6
]}

Garaci, Francesco ^{[7
,8
]}

Bonuccelli, Ubaldo ^{[1
]}

Toschi, Nicola ^{[7
,9
,10
]}

Hampel, Harald ^{[2
,3
,4
,5
]}

机构：

[1] Univ Pisa, Dept Clin & Expt Med, I-56126 Pisa, Italy

[2] Hop La Pitie Salpetriere, Inst Memory & Alzheimers Dis IM2A, Brain & Spine Inst ICM, UMR S 1127,Dept Neurol, F-75651 Paris, France

[3] Pierre & Marie Curie Univ, Sorbonne Univ, Paris VI, F-75005 Paris, France

[4] AXA Res Fund, F-75005 Paris, France

[5] Pierre & Marie Curie Univ Chair, F-75005 Paris, France

[6] Hop La Pitie Salpetriere, IHU A ICM Paris Inst Translat Neurosci, F-75651 Paris, France

[7] Univ Roma Tor Vergata, Dept Biomed & Prevent, Fac Med, I-00173 Rome, Italy

[8] San Raffaele Cassino Nursing Home, I-03043 Cassino, FR, Italy

[9] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA

[10] Harvard Med Sch, Charlestown, MA 02129 USA

来源：

JOURNAL OF SPORT AND HEALTH SCIENCE | 2016年 / 5卷 / 04期

关键词：

ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEMENTIA;

D O I：

10.1016/j.jshs.2016.08.007

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：383 / 387

页数：5

共 50 条

[1] Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Cummings, Jeffrey L.
Teunissen, Charlotte E.
Fiske, Brian K.
Le Ber, Isabelle
Wildsmith, Kristin R.
Schoell, Michael
Dunn, Billy
Scheltens, Philip
NATURE REVIEWS DRUG DISCOVERY, 2025,
[2] Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases
Campese, Nicole
Beatino, Maria Francesca
Del Gamba, Claudia
Belli, Elisabetta
Giampietri, Linda
Del Prete, Eleonora
Galgani, Alessandro
Vergallo, Andrea
Siciliano, Gabriele
Ceravolo, Roberto
Hampel, Harald
Baldacci, Filippo
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (09) : 949 - 967
[3] Biomarker-Guided Tailored Therapy
Lydiard, Jessica
Nemeroff, Charles B.
FRONTIERS IN PSYCHIATRY: ARTIFCIAL INTELLIGENCE, PRECISION MEDICINE, AND OTHER PARADIGM SHIFTS, 2019, 1192 : 199 - 224
[4] Biomarker-Guided Individualization of Antibiotic Therapy
Aulin, Linda B. S.
de Lange, Dylan W.
Saleh, Mohammed A. A.
van der Graaf, Piet H.
Voller, Swantje
van Hasselt, J. G. Coen
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (02) : 346 - 360
[5] The value of biomarker-guided antibiotic therapy
Haag, Ellen
Molitor, Alexandra
Gregoriano, Claudia
Mueller, Beat
Schuetz, Philipp
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (08) : 829 - 840
[6] Biomarker-guided trials: Challenges in practice
Antoniou, M.
Kolamunnage-Dona, R.
Wason, J.
Bathia, R.
Billingham, C.
Bliss, J. M.
Brown, L. C.
Gillman, A.
Paul, J.
Jorgensen, A. L.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 16
[7] GABAPENTIN AS A POTENTIAL BIOMARKER-GUIDED PHARMACOTHERAPY IN ASD
Cochran, David
Kennedy, David N.
Hodge, Steven M.
Mata, Arline
Frazier, Jean A.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S356 - S356
[8] Biomarker-Guided Development of DNA Repair Inhibitors
Cleary, James M.
Aguirre, Andrew J.
Shapiro, Geoffrey I.
D'Andrea, Alan D.
MOLECULAR CELL, 2020, 78 (06) : 1070 - 1085
[9] Blood biomarker-based classification study for neurodegenerative diseases
Jack Kelly
Rana Moyeed
Camille Carroll
Shouqing Luo
Xinzhong Li
Scientific Reports, 13 (1)
[10] Blood biomarker-based classification study for neurodegenerative diseases
Kelly, Jack
Moyeed, Rana
Carroll, Camille
Luo, Shouqing
Li, Xinzhong
SCIENTIFIC REPORTS, 2023, 13 (01):

← 1 2 3 4 5 →